摘要
心源性休克是诸多疾病发展过程中的严重的临床症候群，目前心源性休克院内死亡率仍高达30-50％，静脉-动脉体外膜肺氧合（Artery—venousextracorporealmembraneoxygenation，VA-ECMO）作为体外心肺机械支持的一种方式已逐步应用于心源性休克的治疗。本文从心源性休克病理生理机制、VA—ECMO适应证、禁忌证、并发症及VA—ECMO治疗心源性休克的循证医学证据等几个方面进行介绍。
Cardiogenic shock is a serious clinical syndrome in the development of many diseases. At present, the in-hospital mortality in cardiogenie shock is still as high as 30 - 50%, and the artery-venous ex- tracorporeal membrane oxygenation （ VA-ECMO ） As a method of cardiopulmonary mechanical support in vitro, it has been gradually applied to the treatment of cardiogenic shock. This article reviews several aspects including cardiogenic shock pathophysiology, VA-ECMO indications, contraindications, complications, and EV-ECMO evidence-based medical evidence for cardiogenic shock. [
作者
张劲松
李伟
陈旭峰
梅勇
吕金如
Zhang Jinsong, Li Wei, Chert Xufeng, Mei Yortg, Lv Jinru.(Emergency Department of Jiangsu Provincial People＇s Hospital . Nan- ring, Jiangsu, China)
关键词
心源性休克
静脉-动脉体外膜肺氧合
Cardiogenic shock
Vein-arterial extracorporeal membrane oxygenation
VA-ECMO
